Jim Cramer Says “Buy Eli Lilly”

Eli Lilly and Company (NYSE:LLY) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the market. A caller asked if the stock is a buy, sell, or hold, and Cramer replied:

Okay, everybody’s giving up on Lilly. My experience with Eli Lilly is there are bouts of giving up in this. That’s what I call it, giving up in this. We’re in a giving up in this moment for one of the greatest, if not the greatest, drug company in history. I think the pill is going to be gigantic. People are saying that the… GLP is not big, okay? Not as big as we thought… What can I say? Buy Eli Lilly.

Stock market data. Photo by Alesia Kozik on Pexels

Eli Lilly and Company (NYSE:LLY) develops and markets medicines for diabetes, obesity, oncology, immunology, neuroscience, and other chronic conditions. Cramer was quite bullish on the stock when a caller asked about it during the March 11 episode. He commented:

I like Eli Lilly very much. Look, I always, I never mind [when] anybody takes a profit, it’s always great to take a profit, but we’re holding on for the Charitable Trust. We think that Eli Lilly is one of our favorite stocks. We’re not budging. We’d buy more if it really got hit.

While we acknowledge the risk and potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LLY and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.